They demonstrated that knocking down XIST led to an increased expression of miR-29a and a decreased expression of both MYC protein and mRNA, as well as reduced the tumorigenic ability of AML cells (KG-1) in vivo in mice [98]. This evidence concerns the gene XIST and acute myeloid leukemia.